(Q36794745)

16 August 2017

1 reference

title

Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia (English)

1 reference

16 August 2017

Bor-Ching Sheu

1

1 reference

16 August 2017

Wen-Chun Chang

2

1 reference

16 August 2017

Ho-Hsiung Lin

3

1 reference

16 August 2017

Song-Nan Chow

4

1 reference

16 August 2017

Su-Cheng Huang

5

1 reference

16 August 2017

publication date

1 April 2007

1 reference

Journal of Obstetrics and Gynaecology Research

16 August 2017

published in

1 reference

16 August 2017

volume

33

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

103-113

1 reference

Chapter 5: Updating the natural history of HPV and anogenital cancer

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Human papillomavirus in men: comparison of different genital sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Natural history of cervicovaginal papillomavirus infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

HPV-mediated cervical carcinogenesis: concepts and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Immunology of papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Papillomaviruses: a correlation between immune evasion and oncogenicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

High-risk papillomavirus infection is associated with altered antibody responses in genital tract: non-specific responses in HPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Current concepts of tumor-infiltrating lymphocytes in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Host and viral genetics and risk of cervical cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Integration of high-risk human papillomavirus DNA correlates with HLA genotype aberration and reduced HLA class I molecule expression in human cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Mechanisms of human papillomavirus-induced oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Papillomavirus vaccines in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

How will HPV vaccines affect cervical cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Prevention of cervical cancer through papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Prophylactic HPV vaccines: reducing the burden of HPV-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Chapter 17: Second generation HPV vaccines to prevent cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Induction of Cytotoxic T Lymphocytes With Dendritic Cells Transfected With Human Papillomavirus E6 and E7 RNA: Implications for Cervical Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Down-Regulation of CD25 Expression on the Surface of Activated Tumor-Infiltrating Lymphocytes in Human Cervical Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

Up-regulation of Inhibitory Natural Killer Receptors CD94/NKG2A with Suppressed Intracellular Perforin Expression of Tumor-Infiltrating CD8+T Lymphocytes in Human Cervical Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2007.00492.X

10.1111/J.1447-0756.2007.00492.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference